Coral Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE683E01017
  • NSEID:
  • BSEID: 524506
INR
473.90
4.15 (0.88%)
BSENSE

Dec 05

BSE+NSE Vol: 103

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Smruthi Organic
Sotac Pharma.
Genesis IBRC
Auro Labs.
Panch.Organics
Coral Labs.
Alpa Laboratorie
Pharmaids Pharma
Balaxi Pharma
Natural Capsules
Astonea Labs
Why is Coral Laboratories Ltd ?
1
Poor Management Efficiency with a low ROE of 7.54%
  • The company has been able to generate a Return on Equity (avg) of 7.54% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 1.93% and Operating profit at 5.49% over the last 5 years
3
With a fall in Net Profit of -8.78%, the company declared Very Negative results in Sep 25
  • The company has declared negative results for the last 3 consecutive quarters
  • The company has declared negative results in Mar 25 after 6 consecutive negative quarters
  • NET SALES(Latest six months) At Rs 37.85 cr has Grown at -40.76%
  • PAT(Latest six months) At Rs 8.13 cr has Grown at -46.45%
  • PBT LESS OI(Q) At Rs 4.39 cr has Fallen at -26.71%
4
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 2.14% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -42.76% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Coral Labs. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Coral Labs.
-42.76%
-0.97
43.93%
Sensex
4.81%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.93%
EBIT Growth (5y)
5.49%
EBIT to Interest (avg)
11.76
Debt to EBITDA (avg)
0.24
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.53
Tax Ratio
25.54%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.15%
ROE (avg)
7.54%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
10
Industry P/E
34
Price to Book Value
0.79
EV to EBIT
4.68
EV to EBITDA
4.12
EV to Capital Employed
0.59
EV to Sales
0.75
PEG Ratio
NA
Dividend Yield
0.32%
ROCE (Latest)
12.71%
ROE (Latest)
8.29%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-20What is not working for the Company
NET SALES(Latest six months)

At Rs 37.85 cr has Grown at -40.76%

PAT(Latest six months)

At Rs 8.13 cr has Grown at -46.45%

PBT LESS OI(Q)

At Rs 4.39 cr has Fallen at -26.71%

NON-OPERATING INCOME(Q)

is 38.17 % of Profit Before Tax (PBT

Loading Valuation Snapshot...
Here's what is not working for Coral Labs.
Net Sales - Quarterly
At Rs 19.03 cr has Fallen at -40.96%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 4.39 cr has Fallen at -26.71%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 5.57 cr has Fallen at -12.7%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Non Operating Income - Quarterly
is 38.17 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Non Operating Income - Quarterly
Highest at Rs 2.71 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income